Lamivudine Zidovudine

Product NDC

61919-061

11-digit product format

619190061

Labeler code

61919

Product ID

61919-061_35e360f7-dbde-5dd9-e054-00144ff88e88

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Lamivudine Zidovudine

Dosage form

TABLET

Route

ORAL

Labeler

Direct Rx

Application

ANDA202418

Marketing category

ANDA

Marketing start

2015-01-01

Marketing end

0000-00-00

Substance

LAMIVUDINE; ZIDOVUDINE

Active strength

150 mg/1; mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]

NDC exclude flag

E

Listing certified through

2017-12-31

Current FDA listing

Historical FDA.report record